John O’Mahony

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Structure and Dynamics of Monomer−Template Complexation: An Explanation for Molecularly Imprinted Polymer Recognition Site Heterogeneity

Björn C. G. Karlsson, John O’Mahony, Jesper G. Karlsson et al. · Journal of the American Chemical Society · 2009 · 127 citations

Towards the rational development of molecularly imprinted polymers: 1H NMR studies on hydrophobicity and ion-pair interactions as driving forces for selectivity

John O’Mahony, Alexandra Molinelli, Kieran Nolan et al. · Biosensors and Bioelectronics · 2004 · 98 citations

Engineering, Rational Development, Smart Polymer +10

Ultra-thin flexible screen printed rechargeable polymer battery for wearable electronic applications

Zari Tehrani, T.V. Korochkina, Sridhar Govindarajan et al. · Organic Electronics · 2015 · 89 citations · Full text

Anatomy of a successful imprint: Analysing the recognition mechanisms of a molecularly imprinted polymer for quercetin

John O’Mahony, Alexandra Molinelli, Kieran Nolan et al. · Biosensors and Bioelectronics · 2005 · 81 citations

Pharmacology, Molecular Imprinting, Recognition Mechanisms +1